Navigation Links
REVIVE Trial Results for Avanafil Published in JSM Demonstrate Significant Improvement in Erectile Function
Date:1/17/2012

MOUNTAIN VIEW, Calif., Jan. 17, 2012 /PRNewswire/ -- VIVUS, Inc. (NASDAQ: VVUS) today announced that results from the REVIVE study were published in The Journal of Sexual Medicine (JSM), a peer-reviewed journal with broad, multidisciplinary readership. REVIVE (TA-301) was a randomized, placebo-controlled, phase 3 study evaluating the safety and efficacy of avanafil, an investigational drug currently under review by the Food and Drug Administration (FDA) for the treatment of erectile dysfunction (ED).  In addition to significant improvements in erectile function and low rates of side effects common to phosphodiesterase type 5  inhibitors, the study also found that patients who attempted intercourse within 15 minutes of dosing were successful 64%, 67% and 71% of the time with 50, 100 and 200mg of avanafil treatment, respectively, versus 27% for placebo (p < 0.0001). The data suggest that avanafil may provide a rapid-onset, well-tolerated and effective treatment option for erectile dysfunction.

"While PDE-5 inhibitors are currently used as first-line therapy for treatment of ED in the general population, what's new and novel about avanafil is that it has a fast onset of action and high selectivity," said lead Investigator Irwin Goldstein, MD, Director of San Diego Sexual Medicine at Alvarado Hospital. "For patients, this means that avanafil, if approved, could be taken on-demand with potentially fewer side effects." 

An overview of the results as published in JSM is as follows:

  • Following 12 weeks of treatment, without restrictions on food or alcohol, all three doses of avanafil (50mg, 100mg and 200mg) were significantly superior to placebo for all primary endpoints (p </= 0.001). 
  • A secondary analysis using Sexual Encounter Profile, question 3 (SEP 3) to ev
    '/>"/>

SOURCE VIVUS
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Harvest Technologies Announces Initial Enrollment in Its REVIVE-1 Trial (REtrograde Vascular Infusion of BMAC to ImproVe Heart FailurE)
2. Secret of sandcastle construction could help revive ancient building technique, researchers say
3. Biomerix Corporation Announces FDA Clearance and Market Launch of REVIVE(TM) for Use in Soft Tissue Repair Procedures
4. Neuralstem President and CEO to Update Ongoing ALS and NSI-189/Major Depressive Disorder Trials at 2012 Biotech Showcase
5. NW Bio Reaches 25 Clinical Trial Sites Open and Recruiting By the End of Q4, 2011
6. Baxter Initiates Phase I Clinical Trial of Longer-acting Recombinant FVIII Treatment for Hemophilia A
7. Use Biomarkers in Alzheimers Disease Clinical Trials, Says Expert Group
8. Echo Therapeutics Announces Positive Results of Clinical Trial of its Symphony® Transdermal Continuous Glucose Monitoring (tCGM) System in Patients With Type 1 and Type 2 Diabetes
9. TetraLogic Pharmaceuticals Announces Initiation of a Phase 1/2 Clinical Trial of TL32711 in Patients with Acute Myelogenous Leukemia (AML)
10. US Oncology Research Affiliated Physician to Present Findings From Innovative Clinical Trial at 2011 CTRC-AACR San Antonio Breast Cancer Symposium
11. Post Heart Attack Recovery Not Aided By Stem Cell Injections, But Trial Demonstrates Promise
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2014)... nuclear fuel gets recycled, the process releases radioactive krypton ... basements with the related gas radon. A new porous ... appearing July 20 in Nature Materials shows ... but not out. , The CC3 material could ... from nuclear fuel or air in buildings and also ...
(Date:7/18/2014)... Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that ... operating results on Tuesday, August 5, 2014, before the ... conference call and simultaneous webcast at 8:30 AM Eastern ... access this call, dial (888) 660-6127 (U.S.) or (973) ... accessed from the ,Events and Presentations, page of Regeneron,s ...
(Date:7/18/2014)... is mostly neutral. That is, most of the ... number of electrons in the outer parts of atoms ... atoms. As one or more electrons are plucked ... much stronger positive pull from the nucleus. This ... ensures that those electrons are less vulnerable to the ...
(Date:7/18/2014)... 18, 2014 Global biotechnology company ... offices in Cambridge, MA, announces the launch of ... Software product that leverages the power of Next ... MiSeq sequencing platform. The assay and software have ... of Philadelphia (CHOP) and will include a new ...
Breaking Biology Technology:A noble gas cage 2A noble gas cage 3Highly charged ions 2Highly charged ions 3Highly charged ions 4Omixon Launches Holotype HLA for NGS-based HLA Genotyping 2Omixon Launches Holotype HLA for NGS-based HLA Genotyping 3
... large measure the ability to tune out negativity, author ... of southeastern Wisconsin technology professionals. , ,Kawasaki, managing partner ... "Art of the Start" and several other business books, ... of eInnovate. He poked some good-natured fun at politicians, ...
... may have an expo floor to rival any industry trade show, but ... a sale. , , The BIO Chicago show floor, the size ... globe. "I don't expect any of our end-user customers in the ... of Milwaukee-based Neurognostics said. "This is a probably a better ...
... A stem cell scientist from Harvard University dropped by Wisconsin's ... a hint of admiration, that it was abuzz with activity. ... Wisconsin exhibit than anywhere else I've been on the (exhibit) ... foot traffic at a trade show even one of ...
Cached Biology Technology:Beating back the bozos is an innovation must, says Kawasaki 2As BIO shows mass of competition, hunt for partners is on 2As BIO shows mass of competition, hunt for partners is on 3In competitive biotech world, Wisconsin can't afford to fall behind 2In competitive biotech world, Wisconsin can't afford to fall behind 3
(Date:7/21/2014)... and Dr. Mary Lou Applewhite Distinguished Professor in Department ... to an article in the scientific journal Nature ... into Primate Biology and Evolution," published on July 20. ... mobile elements that move by a sort of "copy ... important because it is the first "New World" monkey ...
(Date:7/21/2014)... La. Dr. Mark DeCoster, the James E. ... Louisiana Tech University, will present as an invited ... at the Biopolis Research and Development Center in ... faculty member in Louisiana Tech,s Institute for Micromanufacturing, ... 2D and 3D cell and tissue models." ...
(Date:7/21/2014)... see an innovation and think, "Of course! Why didn,t ... thoughts of our own invention, sparking ideas and building ... the International Space Station Program Science Office,s new 15-book ... have going on in orbit, their mental wheels may ... encourage investigators to propose new research and potentially make ...
Breaking Biology News(10 mins):LSU's Mark Batzer contributes to Nature Genetics article on marmoset genome 2Louisiana Tech University professor presents at International Bioprinting Congress 2International Space Station researcher guides aim to maximize science 2International Space Station researcher guides aim to maximize science 3International Space Station researcher guides aim to maximize science 4
... at the Southwest Foundation for Biomedical Research (SFBR) in ... levels of bad cholesterol to accumulate in the blood ... studied a strain of laboratory opossums developed at SFBR ... (LDL) cholesterol when fed a standard low-cholesterol diet, but ...
... 14, 2010: 5:00 p.m. U.S. Eastern Time) A new ... groups reveals an ominous finding: most of the world,s ... tradeare now clustered in just six percent of their ... scattered across Asia that are now the last hope ...
... published in the Sept. 15 edition of the Journal ... Edward H. Shortliffe, MD, PhD, points out that although ... role that information management and access play in healthcare ... informatics competency being developed in America,s future corps of ...
Cached Biology News:Scientists find gene for high cholesterol in blood 2Last strongholds for tigers identified in new study 2Last strongholds for tigers identified in new study 3Informatics = essential MD competency 2
Polyclonal antiserum raised against conjugated L-isoleucine. Available as antiserum. Amino Acid Antibodies...
Rabbit polyclonal to FOXJ2 ( Abpromise for all tested applications). entrezGeneID: 55810 SwissProtID: Q9P0K8...
Rabbit polyclonal to Oct2, prediluted ( Abpromise for all tested applications). entrezGeneID: 5452 SwissProtID: P09086...
Macrophage-stimulating protein receptor...
Biology Products: